We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The following certificates were issued on 27 March 2020 and 8 July 2020 by the Comptroller-General of Patents, Designs and Trade Marks.
Veriton Pharma Limited is recalling a specific batch of Epistatus (midazolam) 2.5mg Oromucosal Solution (pre-filled oral syringes) due to confirmed out of specification results related to the product appearance.
ACMD’s report on diversion and illicit supply of medicines.
How to use evidence of drug-related activity and harm to improve prevention and treatment of substance misuse and associated problems.
Information for healthcare professionals to use when discussing medicines with patients that could impair driving.
A summary of international evidence on effective alcohol and drug misuse prevention interventions and examples of their use in England.
Public list of companies in the UK who have had their licence/registration to manufacture or wholesale medicines/ingredients revoked or suspended.
The barriers in accessing the ART and OST services uptake and the experiences of people who inject drugs and service providers
Systemic fluoroquinolones must now only be prescribed when other commonly recommended antibiotics are inappropriate. This follows a review by the MHRA which looked at the effectiveness of current measures to reduce the identified risk of disabling and potentially long-lasting or...
Information about IOM, which allows local and partner agencies to co-ordinate the management of offenders, including details of the Choices programme.
Frequently asked questions on conditional cautions as part of the Drugs Intervention Programme.
Summary of effectiveness, cost-effectiveness and qualitative findings from the Individual Placement and Support - Alcohol and Drug (IPS-AD) study.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).